跳到正文
原文
FierceBiotech· @FierceBiotech · X·· 4 天前AI 评分52
AI 导读

赛诺菲投资的Windward Bio已完成2.25亿美元IPO目标,用于推进其呼吸系统管线。另一家生物科技公司Rezera则以市场状况为由推迟了自己的IPO。

正文

Sanofi-backed Windward Bio has hit its $225M IPO target to advance its respiratory pipeline, even as fellow biotech Rezera delays its own public offering, citing market conditions. https://www.fiercebiotech.com/biotech/sanofi-backed-windward-hits-225m-ipo-goal-advance-respiratory-drugs-china

来源:FierceBiotech · x.com